Your browser doesn't support javascript.
Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2.
Thorne, Lucy G; Bouhaddou, Mehdi; Reuschl, Ann-Kathrin; Zuliani-Alvarez, Lorena; Polacco, Ben; Pelin, Adrian; Batra, Jyoti; Whelan, Matthew V X; Hosmillo, Myra; Fossati, Andrea; Ragazzini, Roberta; Jungreis, Irwin; Ummadi, Manisha; Rojc, Ajda; Turner, Jane; Bischof, Marie L; Obernier, Kirsten; Braberg, Hannes; Soucheray, Margaret; Richards, Alicia; Chen, Kuei-Ho; Harjai, Bhavya; Memon, Danish; Hiatt, Joseph; Rosales, Romel; McGovern, Briana L; Jahun, Aminu; Fabius, Jacqueline M; White, Kris; Goodfellow, Ian G; Takeuchi, Yasu; Bonfanti, Paola; Shokat, Kevan; Jura, Natalia; Verba, Klim; Noursadeghi, Mahdad; Beltrao, Pedro; Kellis, Manolis; Swaney, Danielle L; García-Sastre, Adolfo; Jolly, Clare; Towers, Greg J; Krogan, Nevan J.
  • Thorne LG; Division of Infection and Immunity, University College London, London, UK.
  • Bouhaddou M; QBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
  • Reuschl AK; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.
  • Zuliani-Alvarez L; J. David Gladstone Institutes, San Francisco, CA, USA.
  • Polacco B; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.
  • Pelin A; Division of Infection and Immunity, University College London, London, UK.
  • Batra J; QBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
  • Whelan MVX; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.
  • Hosmillo M; J. David Gladstone Institutes, San Francisco, CA, USA.
  • Fossati A; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.
  • Ragazzini R; QBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
  • Jungreis I; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.
  • Ummadi M; J. David Gladstone Institutes, San Francisco, CA, USA.
  • Rojc A; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.
  • Turner J; QBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
  • Bischof ML; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.
  • Obernier K; J. David Gladstone Institutes, San Francisco, CA, USA.
  • Braberg H; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.
  • Soucheray M; QBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
  • Richards A; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.
  • Chen KH; J. David Gladstone Institutes, San Francisco, CA, USA.
  • Harjai B; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.
  • Memon D; Division of Infection and Immunity, University College London, London, UK.
  • Hiatt J; Division of Virology, Department of Pathology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
  • Rosales R; QBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
  • McGovern BL; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.
  • Jahun A; J. David Gladstone Institutes, San Francisco, CA, USA.
  • Fabius JM; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.
  • White K; Epithelial Stem Cell Biology and Regenerative Medicine Laboratory, The Francis Crick Institute, London, UK.
  • Goodfellow IG; MIT Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA, USA.
  • Takeuchi Y; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Bonfanti P; QBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
  • Shokat K; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.
  • Jura N; J. David Gladstone Institutes, San Francisco, CA, USA.
  • Verba K; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.
  • Noursadeghi M; QBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
  • Beltrao P; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.
  • Kellis M; J. David Gladstone Institutes, San Francisco, CA, USA.
  • Swaney DL; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.
  • García-Sastre A; Division of Infection and Immunity, University College London, London, UK.
  • Jolly C; Division of Infection and Immunity, University College London, London, UK.
  • Towers GJ; QBI Coronavirus Research Group (QCRG), University of California San Francisco, San Francisco, CA, USA.
  • Krogan NJ; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.
Nature ; 604(7905): E14, 2022 Apr.
Article in English | MEDLINE | ID: covidwho-2050413
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Nature Year: 2022 Document Type: Article Affiliation country: S41586-022-04653-w

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Nature Year: 2022 Document Type: Article Affiliation country: S41586-022-04653-w